Immuno-proteasome subunit LMP7 is up-regulated in the ischemic kidney in an experimental model of renovascular hypertension

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 10, 2006, Pages 1778-1785

  Ostrowska, Halina ^a   Kruszewski, Kamil ^a   Kasacka, Irena ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Atrophy; Ischemia; Kidney; LMP immuno subunits; Proteasome; Rat; Renovascular hypertension

Indexed keywords

DODECYL SULFATE SODIUM; LOW MOLECULAR WEIGHT PROTEIN 7; PROTEASOME; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME SUBUNIT; IMMUNOHISTOCHEMISTRY; KIDNEY ATROPHY; KIDNEY CELL; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY HYPERTROPHY; KIDNEY ISCHEMIA; MALE; NEPHRITIS; NONHUMAN; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; HYPERTENSION, RENOVASCULAR; ISCHEMIA; KIDNEY; MALE; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; RATS; RATS, WISTAR; SODIUM DODECYL SULFATE; UP-REGULATION;

EID: 33745342029     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.04.011     Document Type: Article

References (43)

1. Adams P.W., Lee H.S., Waldman W.J., Sedmak D.D., and Orosz C.G. Alloantigenicity of human endothelial cells. III. Quantitated indirect presentation of endothelial alloantigens to human helper T lymphocytes. Transplantation 58 (1994) 476-483
2. Aki M., Shimbara N., Takashina M., Akiyama K., Kagawa S., Tamura T., et al. Interferon-γ induces different subunit organizations and functional diversity of proteasomes. Journal of Biochemistry 115 (1994) 257-269
3. Baumeister W., Dahlmann B., Hergel R., Kopp F., Kuehn L., and Pfeifer G. Electron microscopy and image analysis of the multicatalytic proteinase. FEBS Letters 241 (1988) 239-245
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
5. Ciechanover A. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO Journal 17 (1998) 7151-7160
6. Coux O., Tanaka K., and Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annual Review of Biochemistry 65 (1996) 801-847
7. Dahlmann B., Ruppert T., Kuehn L., Morforth S., and Kloetzel P.M. Different proteasome subtypes in a single tissue exhibit different enzymatic properties. Journal of Molecular Biology 303 (2000) 643-653
8. De Martino G.N., and Slaughter C.A. The proteasome, a novel protease regulated by multiple mechanisms. Journal of Biological Chemistry 274 (1999) 22123-22126
9. Eleuteri A.M., Kohanski R.A., Cardozo C., and Orlowski M. Bovine spleen multicatalytic proteinase complex (proteasome). Replacement of X, Y, and Z subunits by LMP7, LMP2 and MECL1 and changes in properties and specificity. Journal of Biological Chemistry 272 (1997) 11824-11831
10. Elliott P.J., Zollner T.M., and Boehncke W.H. Proteasome inhibition: a new anti-inflammatory strategy. Journal of Molecular Medicine 8 (2003) 235-245
11. Fehling H.J., Swat W., Laplace C., Kuhn R., Rajewski K., Muller U., et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Nature 265 (1994) 1234-1237
12. Gaczynska M., Rock K.L., Spies T., and Goldberg A.L. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex- encoded genes for LMP2 and LMP7. Proceedings of the National Academy of Science of the United States of America, Vol. 91 (1994) 9213-9217
13. Griffin T.A., Nandi D., Cruz M., Fehling H.J., Kaer L.V., Monaco J.J., et al. Immunoproteasome assembly: Cooperative incorporation of interferon γ (IFN-γ)-inducible subunits. Journal of Experimental Medicine 187 (1998) 97-104
14. Groettrup M., Soza A., Eggers M., Kuehn L., Dick T.P., Schild H., et al. A role for the proteasome regulator PA28α in antigen presentation. Nature 381 (1996) 166-168
15. Groll M., Ditzel L., Lowe J., Stock D., Bochtler M., Bartunik H.D., et al. Structure of 20S proteasome from yeast at 2.4A resolution. Nature 386 (1997) 463-471
16. Guijarro C., and Egido J. Transcription factor -κB (NF-κB) and renal desease. Kidney International 59 (2001) 415-424
17. Haller H., Park J.K., Dragun D., Lippoldt A., and Luft F.C. Leukocyte infiltration and ICAM-1 expression in two-kidney one-clip hypertension. Nephrology Dialysis Transplantation 12 (1997) 899-903
18. Hallermalm K., Seki K., Wei C., Castelli C., Rivoltinin L., Kiessling R., et al. Tumor necrosis factor-α induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. Blood 98 (2001) 1108-1115
19. Hisamatsu H., Shimbara N., Saito Y., Kreistensen P., Hendil K.B., Fujiwara T., et al. Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma. Journal of Experimental Medicine 183 (1996) 1807-1816
20. Huang W.C., Ploth D.W., Bell P.D., Work J., and Navar L.G. Bilateral renal function responses to converting enzyme inhibitor (SQ20.881) in two-kidney, one clip Goldblatt hypertensive rats. Hypertension 3 (1981) 285- L293
21. Ingelfinger J.R., and Dzan V.J. Molecular biology of renal injury: emphasies on the role of the renin-angiotensin system. Journal of American Society of Nephrology 2 (1991) S9-S20
22. Khan S., Broek M., Schwartz K., Giuli R., Diener P.A., and Groettrup M. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune responses in the liver. Journal of Immunology 167 (2001) 6859-6868
23. Klachr S., and Morrissey J. Angiotensin II and gene expression in the kidney. American Journal of Kidney Diseases 31 (1998) 171-176
24. Kloetzel P.M., and Ossendorp F. Proteasome and peptidase function in MHC-class I-mediated antigen presentation. Current Opinion in Immunology 16 (2004) 76-81
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T. Nature 227 (1970) 680-685
26. Loukissa A., Cardozo C., Altschuller-Felberg C., and Nelson J.E. Control of LMP7 expression in human endothelial cells by cytokines regulating cellular and humoral immunity. Cytokine 12 (2000) 1326-1330
27. Mai M., Geiger H., Hilgers K.F., Veelken R., Mann J.F., Dammrich J., et al. Early interstitial changes in hypertension-induced renal injury. Hypertension 22 (1993) 754-765
28. Muller D.N., Dechend R., Mervaala E.M., Park J.K., Schmidt F., Fiebeler A., et al. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35 (2000) 193-201
29. Nelson J.E., Loukissa A., Altschuller-Felberg C., Monaco J.J., Fallon J.T., and Cardozo C. Up-regulation of the proteasome subunit LMP7 in tissues of endotoxemic rats. Journal of Laboratory and Clinical Medicine 135 (2000) 324-331
30. Noda C., Tanahashi N., Shimbara N., Hendil K.B., and Tanaka K. Tissue distribution of constitutive proteasomes, immunoproteasomes and PA28 in rats. Biochemical and Biophysics Research Communications 277 (2000) 348-354
31. Ostrowska J.K., Wojtukiewicz M.Z., Chabielska E., Buczko W., and Ostrowska H. Proteasome inhibitor prevents experimental arterial thrombosis in renovascular hypertensive rats. Thrombosis and Haemostasis 92 (2004) 171-177
32. Palombella V.J., Rando O.J., Goldberg A.L., and Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappaB1 precursor protein and the activation of NF-kappaB. Cell 78 (1994) 773-785
33. Rechsteiner M., Realini C., and Ustrell V. The proteasome activator 11S (PA28) and class I antigen presentation. Biochemical Journal 345 (2000) 1-15
34. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78 (1994) 761-771
35. Rodgers K.J., and Dean R.T. Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates. International Journal of Biochemistry and Cell Biology 35 (2003) 716-727
36. Rundback J.H., Murphy T.P., Cooper M.D., and Weintraub M.D. Chronic renal ischemia: pathophysiologic mechanisms of cardiovascular and renal disease. Journal of Vascular Intervention and Radiology 13 (2002) 1085-1092
37. Satoh K., Sasajima H., Nyoumura K., Yokosawa H., and Sawada H. Assembly of the 26S proteasome is regulated by phosphorylation of the p45/Rpt6 ATPase subunit. Biochemistry 40 (2001) 314-319
38. Shibatani T., and Ward W.F. Sodium dodecyl sulfate (SDS) activation of the 20S proteasome in rat liver. Archives of Biochemistry and Biophysics 321 (1995) 160-166
39. Takaoka M., Ohkita M., and Matsumura Y. Pathophysiological role of proteasome-dependent proteolytic pathway in endothelin-1-related cardiovascular diseases. Current Vascular Pharmacology 1 (2003) 19-26
40. Tanahashi N., Murakami Y., Minami Y., Shimbara N., Hendil K.B., and Tanaka K. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. Journal of Biological Chemistry 275 (2000) 14336-14345
41. Tanaka K., and Kasahara M. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-γ-inducible proteasome activator PA28. Immunological Review 163 (1998) 161-176
42. Tashiro K., Tamada S., Kuwabara N., Komiya T., Takekida K., Asai T., et al. Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor κB. International Journal of Molecular Medicine 12 (2003) 587-592
43. Taylor C.T. Regulation of intestinal epithelial gene expression in hypoxia. Kidney International 66 (2004) 528-531